Orion, Mylan settle patent dispute over Parkinson's drug Stalevo

HELSINKI Thu Jul 25, 2013 5:50am EDT

Related Topics

HELSINKI (Reuters) - Finnish drug maker Orion said that it settled a patent lawsuit in the United States against Mylan Pharmaceuticals over Mylan's application to sell a generic version of Orion's Parkinson's drug Stalevo.

Orion did not disclose the terms of their settlement, but said Mylan would be authorized to launch generic versions of the Stalevo drug.

(Reporting by Ritsuko Ando; editing by Keiron Henderson)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.